Since increased expression of IGFBP1, CD36 and cytochemokines such as CCL2 promotes NASH progression in Wtap-HKO mice, we next asked how WTAP regulated their expression. The gene discussed is WTAP; the disease is metabolic dysfunction-associated steatohepatitis.